{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:43:25Z","timestamp":1793447005125,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002657","name":"Istanbul University","doi-asserted-by":"publisher","award":["FDK-2024-40841"],"award-info":[{"award-number":["FDK-2024-40841"]}],"id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110013","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T15:08:07Z","timestamp":1779548887000},"page":"110013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Identification of a nanomolar, selective MAO-B inhibitor from piperidine-based chalcones with anti-Parkinson potential"],"prefix":"10.1016","volume":"179","author":[{"given":"Azize","family":"Kirac-Aydin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishnu Prasad","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyajit","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupsa","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok Kumar","family":"Pattnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Tarbin","family":"Jannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay N.","family":"Basavanakatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil\u00fcfer","family":"Bayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesan","family":"Jayaprakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ama\u00e7 Fatih","family":"TuYuN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2026.110013_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031851","article-title":"A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics","volume":"23","author":"Lamptey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.bioorg.2026.110013_bb0010","doi-asserted-by":"crossref","first-page":"12613","DOI":"10.3390\/ijms252312613","article-title":"Decoding neurodegeneration: a review of molecular mechanisms and therapeutic advances in Alzheimer\u2019s, Parkinson\u2019s, and ALS","volume":"25","author":"Toader","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110013_bb0015","article-title":"Pyrimidine analogues for the management of neurodegenerative diseases","volume":"6","author":"Pant","year":"2022","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.bioorg.2026.110013_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148674","article-title":"Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: multiple sclerosis","volume":"1822","author":"Gadhave","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.bioorg.2026.110013_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.952161","article-title":"Global, regional, and national burden and attributable risk factors of neurological disorders: the global burden of disease study 1990-2019","volume":"10","author":"Ding","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.bioorg.2026.110013_bb0030","article-title":"The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990\u20132019: findings from the Global Burden of Disease Study 2019","volume":"16","author":"Castelpietra","year":"2022","journal-title":"Lancet Reg. Health Eur."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110013_bb0035","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease","volume":"9","author":"Kehagia","year":"2010","journal-title":"The Lancet Neurology"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110013_bb0040","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson's disease: risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"The Lancet Neurology"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110013_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26031248","article-title":"Monoamine oxidase inhibitors in toxic models of parkinsonism","volume":"26","author":"Buneeva","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110013_bb0050","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3233\/JPD-212976","article-title":"Monoamine oxidase-B inhibitors for the treatment of Parkinson\u2019s disease: past, present, and future","volume":"12","author":"Tan","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110013_bb0055","doi-asserted-by":"crossref","first-page":"308","DOI":"10.37349\/ent.2024.00085","article-title":"An overview of the role of monoamine oxidase-B in Parkinson\u2019s disease: implications for neurodegeneration and therapy","volume":"4","author":"Chandra Sekar","year":"2024","journal-title":"exploration of neuroprotective Therapy"},{"key":"10.1016\/j.bioorg.2026.110013_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00143","article-title":"Monoamine oxidases (MAOs) as privileged molecular targets in neuroscience: research literature analysis","volume":"12","author":"Yeung","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110013_bb0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1515\/BMC.2011.030","article-title":"Structures and mechanism of the monoamine oxidase family","volume":"2","author":"Gaweska","year":"2011","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.bioorg.2026.110013_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2021.101957","article-title":"The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders","volume":"114","author":"Jones","year":"2021","journal-title":"J. Chem. Neuroanat."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110013_bb0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/13543776.2018.1427735","article-title":"MAO inhibitors and their wider applications: a patent review","volume":"28","author":"Carradori","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110013_bb0080","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/13543776.2026.2633345","article-title":"Patents involving monoamine oxidase (MAO): a comprehensive update (2022-2025) on its inhibitors and applications","volume":"36","author":"Shaldam","year":"2026","journal-title":"Expert Opin. Ther. Pat."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110013_bb0085","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s40263-023-01048-x","article-title":"Efficacy and safety of MAO-B inhibitors safinamide and Zonisamide in Parkinson\u2019s disease: a systematic review and Meta-analysis of randomized controlled trials","volume":"37","author":"Aboulatta","year":"2023","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110013_bb0090","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/0929867043455594","article-title":"Trends in the development of new antidepressants. Is there a light at the end of the tunnel?","volume":"11","author":"Pacher","year":"2004","journal-title":"Curr. Med. Chem."},{"issue":"48","key":"10.1016\/j.bioorg.2026.110013_bb0095","doi-asserted-by":"crossref","first-page":"42660","DOI":"10.1039\/C6RA00302H","article-title":"Recent developments on the structure\u2013activity relationship studies of MAO inhibitors and their role in different neurological disorders","volume":"6","author":"Kumar","year":"2016","journal-title":"RSC Adv."},{"issue":"17","key":"10.1016\/j.bioorg.2026.110013_bb0100","doi-asserted-by":"crossref","first-page":"6717","DOI":"10.1021\/jm501690r","article-title":"New Frontiers in selective human MAO-B inhibitors","volume":"58","author":"Carradori","year":"2015","journal-title":"J. Med. Chem."},{"issue":"25","key":"10.1016\/j.bioorg.2026.110013_bb0105","doi-asserted-by":"crossref","first-page":"26208","DOI":"10.1021\/acsomega.5c00134","article-title":"New prospects in the inhibition of monoamine oxidase-B (MAO-B) utilizing Propargylamine derivatives for the treatment of Alzheimer\u2019s disease: a review","volume":"10","author":"Chatzipieris","year":"2025","journal-title":"ACS Omega"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110013_bb0110","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.3390\/molecules28124814","article-title":"Structure-based Design of Novel MAO-B inhibitors: a review","volume":"28","author":"Mateev","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110013_bb0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1017\/S1092852913000886","article-title":"Compulsivity and impulsivity\u2014personal reflections: why now and why here?","volume":"19","author":"Hollander","year":"2014","journal-title":"CNS Spectr."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110013_bb0120","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bmcl.2005.10.013","article-title":"Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin\u2013resveratrol hybrids","volume":"16","author":"Vilar","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110013_bb0125","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.bmcl.2009.03.030","article-title":"Inhibition of monoamine oxidase by (E)-styrylisatin analogues","volume":"19","author":"Van der Walt","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.bioorg.2026.110013_bb0130","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1021\/bi9002106","article-title":"Development of spin-labeled Pargyline analogues as specific inhibitors of human monoamine oxidases a and B","volume":"48","author":"Upadhyay","year":"2009","journal-title":"Biochemistry-Us"},{"issue":"33","key":"10.1016\/j.bioorg.2026.110013_bb0135","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.2174\/092986711797636090","article-title":"The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant\/anticonvulsant agents","volume":"18","author":"Secci","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2026.110013_bb0140","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1016\/j.bmcl.2010.06.128","article-title":"Identification of novel monoamine oxidase B inhibitors by structure-based virtual screening","volume":"20","author":"Geldenhuys","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110013_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24030418","article-title":"Quercetin and related Chromenone derivatives as monoamine oxidase inhibitors: targeting neurological and mental disorders","volume":"24","author":"Dhiman","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110013_bb0150","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainres.2007.11.051","article-title":"CSC, an adenosine A2A receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats","volume":"1191","author":"Aguiar","year":"2008","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110013_bb0155","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s11030-023-10634-6","article-title":"Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach","volume":"28","author":"Baweja","year":"2024","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2026.110013_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112265","article-title":"Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease","volume":"194","author":"Sang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110013_bb0165","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/acschemneuro.3c00679","article-title":"Design, synthesis, and biological evaluation of Ferulic acid template-based novel multifunctional ligands targeting NLRP3 Inflammasome for the Management of Alzheimer\u2019s disease","volume":"15","author":"Singh","year":"2024","journal-title":"ACS Chem. Nerosci."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110013_bb0170","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10311-019-00959-w","article-title":"Chalcone synthesis, properties and medicinal applications: a review","volume":"18","author":"Rammohan","year":"2020","journal-title":"Environ. Chem. Lett."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110013_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22081210","article-title":"Chalcone derivatives: promising starting points for drug design","volume":"22","author":"Gomes","year":"2017","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110013_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ph15101250","article-title":"Chalcone: a promising bioactive scaffold in medicinal chemistry","volume":"15","author":"Rajendran","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110013_bb0185","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: a privileged structure in medicinal chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110013_bb0190","article-title":"The green chemistry of chalcones: valuable sources of privileged core structures for drug discovery","volume":"10\u20132022","author":"Marotta","year":"2022","journal-title":"Front. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110013_bb0195","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1021\/jm801590u","article-title":"Chalcones: a valid scaffold for monoamine oxidases inhibitors","volume":"52","author":"Chimenti","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110013_bb0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bioorg.2015.07.001","article-title":"Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: synthesis, biochemistry and molecular docking studies","volume":"62","author":"Mathew","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110013_bb0205","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejmech.2016.02.038","article-title":"Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors","volume":"114","author":"Hammuda","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110013_bb0210","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.ijbiomac.2017.05.162","article-title":"Monoamine oxidase inhibitory activity of methoxy-substituted chalcones","volume":"104 Pt A","author":"Mathew","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2026.110013_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112650","article-title":"Chalcones: unearthing their therapeutic possibility as monoamine oxidase B inhibitors","volume":"205","author":"Guglielmi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110013_bb0220","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2174\/1386207324666210603125452","article-title":"Trimethoxy Crown Chalcones as multifunctional class of Monoamine Oxidase enzyme inhibitors","volume":"25","author":"Maliyakkal","year":"2021","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.bioorg.2026.110013_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13060850","article-title":"Trimethoxylated halogenated chalcones as dual inhibitors of MAO-B and BACE-1 for the treatment of neurodegenerative disorders","volume":"13","author":"Vishal","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2026.110013_bb0230","doi-asserted-by":"crossref","unstructured":"N.A. Rehuman, J. Oh, M. Abdelgawad, E. Beshr, M. Abourehab, N. Gambacorta, O. Nicolotti, R. Jat, H. Kim, B. Mathew, Development of halogenated-chalcones bearing with dimethoxy phenyl head as monoamine oxidase-B inhibitors, Pharmaceuticals-Base 15 (2022).","DOI":"10.3390\/ph15091152"},{"key":"10.1016\/j.bioorg.2026.110013_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-26929-x","article-title":"Introduction of benzyloxy pharmacophore into aryl\/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors","volume":"12","author":"Sudevan","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110013_bb0240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/cbdd.14238","article-title":"Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones","volume":"102","author":"Singh","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"issue":"17","key":"10.1016\/j.bioorg.2026.110013_bb0245","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1016\/j.bmcl.2013.06.050","article-title":"Selected furanochalcones as inhibitors of monoamine oxidase","volume":"23","author":"Robinson","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110013_bb0250","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/molecules23040831","article-title":"Synthesis and Anticandidal activity of new imidazole-Chalcones","volume":"23","author":"Osmaniye","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110013_bb0255","doi-asserted-by":"crossref","unstructured":"N.G. Bajad, R.B. Singh, G. T.A, G. Gutti, A. Kumar, S. Krishnamurthy, S.K. Singh, Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer's disease, Bioorg. Chem. 143 (2024) 107082.","DOI":"10.1016\/j.bioorg.2023.107082"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110013_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/ph16010083","article-title":"Identification of new N-methyl-piperazine Chalcones as dual MAO-B\/AChE inhibitors","volume":"16","author":"El-Damasy","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110013_bb0265","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/14756366.2020.1842390","article-title":"Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations","volume":"36","author":"Sasidharan","year":"2021","journal-title":"J Enzym Inhib Med Ch"},{"key":"10.1016\/j.bioorg.2026.110013_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103034","article-title":"Ultrasound-assisted synthesis of novel chalcone, heterochalcone and bis-chalcone derivatives and the evaluation of their antioxidant properties and as acetylcholinesterase inhibitors","volume":"90","author":"Polo","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110013_bb0275","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/ph18030309","article-title":"Microwave-assisted synthesis of Morpholine-based Chalcones as reversible MAO-A inhibitors in the Management of Mental Depression","volume":"18","author":"Choudhary","year":"2025","journal-title":"Pharmaceuticals-Base"},{"key":"10.1016\/j.bioorg.2026.110013_bb0280","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejmech.2017.05.026","article-title":"QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity","volume":"137","author":"Gomes","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110013_bb0285","doi-asserted-by":"crossref","first-page":"16187","DOI":"10.1039\/D5RA01929J","article-title":"Exploring N-heterocyclic linked novel hybrid chalcone derivatives: synthesis, characterization, evaluation of antidepressant activity, toxicity assessment, molecular docking, DFT and ADME study","volume":"15","author":"Deshmukh","year":"2025","journal-title":"Rsc Adv"},{"key":"10.1016\/j.bioorg.2026.110013_bb0290","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1021\/acsomega.4c11066","article-title":"Microwave-assisted synthesis of near-infrared Chalcone dyes: a systematic approach","volume":"10","author":"Baqi","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110013_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1389848","article-title":"Green synthesis, structure\u2013activity relationships, in silico molecular docking, and antifungal activities of novel prenylated chalcones","volume":"12","author":"Godara","year":"2024","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2026.110013_bb0300","doi-asserted-by":"crossref","first-page":"101912","DOI":"10.1016\/j.rechem.2024.101912","article-title":"Rapid synthesis and antifungal evaluation of prenylated chalcones: A structure-activity relationship and molecular docking study","volume":"12","author":"Godara","year":"2024","journal-title":"Results Chem."},{"key":"10.1016\/j.bioorg.2026.110013_bb0305","series-title":"Zulhipri","author":"Seflini","year":"2024"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110013_bb0310","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/bkcs.12088","article-title":"Microwave-assisted synthesis and molecular docking study of Heteroaromatic Chalcone derivatives as potential antibacterial agents","volume":"41","author":"Farooq","year":"2020","journal-title":"B Kor Chem Soc"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110013_bb0315","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson\u2019s disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bioorg.2026.110013_bb0320","series-title":"Mood and Anxiety Related Phenotypes in Mice: Characterization Using Behavioral Tests","first-page":"1","article-title":"The open field test","author":"Gould","year":"2009"},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2026.110013_bb0325","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00044-X","article-title":"Discrimination of morphine- and haloperidol-induced muscular rigidity and akinesia\/catalepsy in simple tests in rats","volume":"134","author":"Fischer","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bioorg.2026.110013_bb0330","series-title":"Pole Test Assessment","author":"Krout","year":"2024"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110013_bb0335","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbr.2004.09.004","article-title":"Structure of the rat behaviour in the Forced Swimming Test","volume":"158","author":"Lino-de-Oliveira","year":"2005","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110013_bb0340","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneumeth.2010.03.026","article-title":"A rotarod test for evaluation of motor skill learning","volume":"189","author":"Shiotsuki","year":"2010","journal-title":"J. Neurosci. Methods"},{"issue":"Part_3","key":"10.1016\/j.bioorg.2026.110013_bb0345","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.matpr.2019.12.120","article-title":"Cu2+\/zeolite catalyzed aldol condensation: greener synthesis of 4\u2032-piperidinophenyl enones","volume":"22","author":"Ranganathan","year":"2020","journal-title":"Mater. Today Proc."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110013_bb0350","first-page":"703","article-title":"Synthesis and evaluation of chalcone derivatives as novel anticancer agents","volume":"39","author":"Sheng","year":"2019","journal-title":"Youji Huaxue"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110013_bb0355","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1747-0285.2012.01383.x","article-title":"Antimalarial activity of newly synthesized chalcone derivatives in vitro","volume":"80","author":"Yadav","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110013_bb0360","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4155\/fmc-2022-0317","article-title":"Synthetic piperidine-substituted chalcones as potential hits for \u03b1-amylase inhibitory and antioxidant activities","volume":"15","author":"Haq","year":"2023","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110013_bb0365","first-page":"49","article-title":"Virtual screening and docking studies of synthesized chalcones: potent anti-malarial drug","volume":"8","author":"Singh","year":"2016","journal-title":"Int. J. Drug Dev. Res."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110013_bb0370","first-page":"1623","article-title":"Microwave enhanced Claisen-Schmidt condensation: a green route to chalcones","volume":"51B","author":"Singh","year":"2012","journal-title":"Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2026.110013_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25173896","article-title":"Inhibition of Butyrylcholinesterase and human monoamine oxidase-B by the Coumarin Glycyrol and Liquiritigenin isolated from Glycyrrhiza uralensis","volume":"25","author":"Jeong","year":"2020","journal-title":"Molecules"},{"issue":"42","key":"10.1016\/j.bioorg.2026.110013_bb0380","doi-asserted-by":"crossref","first-page":"28182","DOI":"10.1021\/acsomega.1c04252","article-title":"Halogenated Coumarin\u2013Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors","volume":"6","author":"Rehuman","year":"2021","journal-title":"ACS Omega"},{"issue":"19","key":"10.1016\/j.bioorg.2026.110013_bb0385","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1016\/j.bmcl.2016.08.044","article-title":"Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens","volume":"26","author":"Lee","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2026.110013_bb0390","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"16","key":"10.1016\/j.bioorg.2026.110013_bb0395","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2026.110013_bb0400","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1016\/j.bmcl.2008.10.084","article-title":"Pyrazoline-based mycobactin analogues as MAO-inhibitors","volume":"18","author":"Jayaprakash","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"W1","key":"10.1016\/j.bioorg.2026.110013_bb0405","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.bioorg.2026.110013_bb0410","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: fully automated protein\u2013ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.110013_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2020.126680","article-title":"Glycine nano-selenium prevents brain oxidative stress and neurobehavioral abnormalities caused by MPTP in rats","volume":"64","author":"Yue","year":"2021","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110013_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10112929","article-title":"Neuroprotective effects of nicotinamide against MPTP-induced Parkinson\u2019s disease in mice: impact on oxidative stress, Neuroinflammation, Nrf2\/HO-1 and TLR4 signaling pathways","volume":"10","author":"Rehman","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2026.110013_bb0425","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbr.2014.04.022","article-title":"Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson\u2019s disease rat model","volume":"268","author":"Ho","year":"2014","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110013_bb0430","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11064-010-0289-x","article-title":"Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency","volume":"36","author":"Sengupta","year":"2011","journal-title":"Neurochem. Res."},{"issue":"14","key":"10.1016\/j.bioorg.2026.110013_bb0435","doi-asserted-by":"crossref","first-page":"13016","DOI":"10.1021\/acsomega.3c00201","article-title":"Protective effect of Hirsutidin against rotenone-induced parkinsonism via inhibition of Caspase-3\/Interleukins-6 and 1\u03b2","volume":"8","author":"Nadeem","year":"2023","journal-title":"ACS Omega"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826005493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826005493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:43:32Z","timestamp":1783129412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826005493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":87,"alternative-id":["S0045206826005493"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110013","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a nanomolar, selective MAO-B inhibitor from piperidine-based chalcones with anti-Parkinson potential","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110013"}}